OCGN - Ocugen - Stock Price & Catalysts • BiopharmIQ

Enterprise Value

39.95M

Cash

70.58M

Avg Qtr Burn

-17.07M

Short % of Float

9.62%

Insider Ownership

1.51%

Institutional Own.

24.21%

Qtr Updated

06/30/23

Drug Pipeline

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
NeoCart® (Autologous chondrocyte-derived neocartilage) Details Articular cartilage defects in the knee	Phase 3 Initiation	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
OCU400 Details Retinitis Pigmentosa	Phase 3 Initiation	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
COVAXIN (BBV152) Details COVID-19, Infectious disease	Phase 2/3 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
OCU410ST Details Stargardt disease, Rare genetic disease	Phase 1/2 Initiation	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
OCU410 Details Geographic atrophy	Phase 1/2 Initiation	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.